Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EXFO’s life sciences division goes to private buyer

This article was originally published in Clinica

Executive Summary

Private equity firm The Riverside Company has purchased the life sciences and industrial division of EXFO, a Canadian telecommunications specialist, for an undisclosed fee. The division markets cellular imaging technology such as the X-Cite fluorescence illumination system and UV bonding products, including the OmniCure S2000 catheter assembly system. Riverside will rename the business, based in Mississauga, Ontario, The Lumen Diagnostics Group (LDG). The EXFO group said the divested division only accounts for 10% of its revenues (its telecommunications business accounts for 90%) and in fiscal 2009, life sciences sales had dropped 13% to $19.8m due to a decline in demand for products. However, Riverside believes that LDG has "enormous growth potential", with a unique patent portfolio and strong management team, among other things. Riverside’s investment portfolio already includes IVD test kits developer GTI Diagnostics, clinical and lab testing products firm Novamed and disposable, single-used medical device maker Summit Medical.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts